AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34029230 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized postoperative anesthesia visits on day 1 and 3
Number of subjects: 5473
Study 34029230 — intervention group
Group type: COMPARATOR
Intervention: Routine use of MEWS
Number of subjects: 5473
Study 34029230 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized postoperative anesthesia visits
Number of subjects: 5473
Study 34406788 — intervention group
Group type: EXPERIMENTAL
Intervention: Conidial suspension (1 × 10^6 conidia/ml) inoculation on three leaves of three plants
Number of subjects: 100
Study 34406788 — intervention group
Group type: EXPERIMENTAL
Intervention: Mycelial plugs (5 × 5 mm3) inoculation on three leaves of three plants
Number of subjects: 100
Study 34406788 — intervention group
Group type: COMPARATOR
Intervention: Mock inoculations with sterile water and non-infested PDA plugs on three leaves each
Number of subjects: 100
Study 32794449 — intervention group
Group type: EXPERIMENTAL
Intervention: Online imaginal exposure therapy for EDs (4 sessions over 4 weeks)
Number of subjects: 229
Study 35358015 — intervention group
Group type: EXPERIMENTAL
Intervention: 4vHPV vaccine
Number of subjects: 368
Study 35358015 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 368
Study 33386202 — intervention group
Group type: EXPERIMENTAL
Intervention: Submental island flap reconstruction
Number of subjects: 60
Study 33386202 — intervention group
Group type: COMPARATOR
Intervention: Maxillary obturator reconstruction
Number of subjects: 60
Study 32358477 — intervention group
Group type: EXPERIMENTAL
Intervention: Fascia iliaca block (FIB)
Number of subjects: 97
Study 32358477 — intervention group
Group type: COMPARATOR
Intervention: Control group (no block)
Number of subjects: 97
Study 35851045 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide/formoterol 200/6 μg via turbuhaler
Number of subjects: 49
Study 35851045 — intervention group
Group type: COMPARATOR
Intervention: Salbutamol 100 μg via MDI
Number of subjects: 49
Study 32108027 — intervention group
Group type: EXPERIMENTAL
Intervention: High-density lipoprotein (HDL)
Number of subjects: 10686
Study 32108027 — intervention group
Group type: EXPERIMENTAL
Intervention: Triglycerides (TG)
Number of subjects: 10686
Study 35889801 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise and Fish Oil (EFO)
Number of subjects: 34
Study 35889801 — intervention group
Group type: COMPARATOR
Intervention: Exercise and Placebo (EP)
Number of subjects: 34
Study 35889801 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 34
Study 32957817 — intervention group
Group type: EXPERIMENTAL
Intervention: Truncal ITA ligation
Number of subjects: 319
Study 32957817 — intervention group
Group type: COMPARATOR
Intervention: Branch ITA ligation
Number of subjects: 319
Study 36137682 — intervention group
Group type: EXPERIMENTAL
Intervention: Apixaban 5 mg twice daily
Number of subjects: 762
Study 36137682 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (vitamin K antagonists or antiplatelet therapy)
Number of subjects: 762
Study 36137682 — intervention group
Group type: EXPERIMENTAL
Intervention: Apixaban vs antiplatelet therapy
Number of subjects: 762
Study 36137682 — intervention group
Group type: EXPERIMENTAL
Intervention: Apixaban vs vitamin K antagonists
Number of subjects: 762
Study 36137682 — intervention group
Group type: EXPERIMENTAL
Intervention: Subclinical valve thrombosis
Number of subjects: 762
Study 36137682 — intervention group
Group type: COMPARATOR
Intervention: No subclinical valve thrombosis
Number of subjects: 762
Study 34217889 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy-based pain coping skills training with optional opioid taper support (18 telephone sessions over 52 weeks)
Number of subjects: 215
Study 34217889 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 215
Study 34217889 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy-based pain coping skills training with optional opioid taper support
Number of subjects: 215
Study 34842343 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega 3 fatty acids 1000 mg/day for 6 months
Number of subjects: 60
Study 34842343 — intervention group
Group type: COMPARATOR
Intervention: Usual doxorubicin protocol
Number of subjects: 60
Study 34374980 — intervention group
Group type: EXPERIMENTAL
Intervention: Thoracolumbar interfascial plane (TLIP) block with ultrasound guidance
Number of subjects: 42
Study 34374980 — intervention group
Group type: COMPARATOR
Intervention: Local anesthetic infiltration (bupivacaine) on the surgical incision line
Number of subjects: 42
Study 34644414 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxorubicin with dexrazoxane
Number of subjects: 1308
Study 34644414 — intervention group
Group type: COMPARATOR
Intervention: Doxorubicin without dexrazoxane
Number of subjects: 1308
Study 34644414 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexrazoxane (P9754 patients)
Number of subjects: 1308
Study 34644414 — intervention group
Group type: COMPARATOR
Intervention: CCSS osteosarcoma survivors (no dexrazoxane)
Number of subjects: 1308
Study 33069121 — intervention group
Group type: EXPERIMENTAL
Intervention: Memantine (5 mg/day)
Number of subjects: 155
Study 33069121 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 155
Study 35174649 — intervention group
Group type: EXPERIMENTAL
Intervention: semaglutide 0.5 mg
Number of subjects: 909
Study 35174649 — intervention group
Group type: EXPERIMENTAL
Intervention: semaglutide 1.0 mg
Number of subjects: 909
Study 35174649 — intervention group
Group type: COMPARATOR
Intervention: comparators (sitagliptin or OADs)
Number of subjects: 909
Study 32757086 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed loop stimulation (CLS)
Number of subjects: 9
Study 32757086 — intervention group
Group type: COMPARATOR
Intervention: Standard accelerometer (DDDR)
Number of subjects: 9
Study 35921055 — intervention group
Group type: EXPERIMENTAL
Intervention: Team-guided ICBT
Number of subjects: 178
Study 35921055 — intervention group
Group type: COMPARATOR
Intervention: Self-guided ICBT
Number of subjects: 178
Study 32324065 — intervention group
Group type: EXPERIMENTAL
Intervention: Ertugliflozin 5 mg
Number of subjects: 1178
Study 32324065 — intervention group
Group type: EXPERIMENTAL
Intervention: Ertugliflozin 15 mg
Number of subjects: 1178
Study 32324065 — intervention group
Group type: COMPARATOR
Intervention: Glimepiride
Number of subjects: 1178
Study 32324065 — intervention group
Group type: EXPERIMENTAL
Intervention: Ertugliflozin 5 mg/sitagliptin
Number of subjects: 1178
Study 32324065 — intervention group
Group type: EXPERIMENTAL
Intervention: Ertugliflozin 15 mg/sitagliptin
Number of subjects: 1178
Study 32324065 — intervention group
Group type: COMPARATOR
Intervention: Sitagliptin
Number of subjects: 1178
Study 32324065 — intervention group
Group type: EXPERIMENTAL
Intervention: Ertugliflozin (as single agent or combined with sitagliptin)
Number of subjects: 1178
Study 32324065 — intervention group
Group type: EXPERIMENTAL
Intervention: Ertugliflozin
Number of subjects: 1178
Study 35568494 — intervention group
Group type: COMPARATOR
Intervention: COT (Conventional Occupational Therapy)
Number of subjects: 60
Study 35568494 — intervention group
Group type: EXPERIMENTAL
Intervention: COT+CCH (Conventional Occupational Therapy + Chinese Calligraphy Handwriting)
Number of subjects: 60
Study 35568494 — intervention group
Group type: EXPERIMENTAL
Intervention: COT+GRASP (Conventional Occupational Therapy + Graded Repetitive Arm Supplementary Program)
Number of subjects: 60
Study 33345396 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab
Number of subjects: 0
Study 33345396 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy (docetaxel or paclitaxel)
Number of subjects: 0
Study 32794176 — intervention group
Group type: EXPERIMENTAL
Intervention: Transnasal Humidified Rapid‐Insufflation Ventilatory Exchange (THRIVE) with 100% oxygen at 70 l min−1 during apnoea
Number of subjects: 30
Study 32794176 — intervention group
Group type: COMPARATOR
Intervention: Mechanical ventilation with intubation and normoventilation at FiO2 of 0.4
Number of subjects: 30
Study 33057772 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined Model consisting of 2 clinical factors, 2 tumor markers, 7 PET radiomics, and 3 CT radiomic parameters
Number of subjects: 315
Study 33057772 — intervention group
Group type: COMPARATOR
Intervention: Clinical factors-tumor markers
Number of subjects: 315
Study 33057772 — intervention group
Group type: COMPARATOR
Intervention: PET radiomics
Number of subjects: 315
Study 33057772 — intervention group
Group type: COMPARATOR
Intervention: CT radiomics
Number of subjects: 315
Study 35906655 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactation-specific relaxation and visualisation intervention
Number of subjects: 132
Study 32738099 — intervention group
Group type: EXPERIMENTAL
Intervention: Dinaciclib (6-12 mg/m2 i.v.) and MK-2206 (60-135 mg p.o.) weekly
Number of subjects: 39
Study 32738099 — intervention group
Group type: EXPERIMENTAL
Intervention: Dinaciclib (9 mg/m2) and MK-2206 (135 mg) at recommended dose
Number of subjects: 39
Study 32738099 — intervention group
Group type: EXPERIMENTAL
Intervention: Dinaciclib and MK-2206 combination
Number of subjects: 39
Study 35144911 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug trials in GP practices
Number of subjects: 87
Study 36006207 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A (BoNT‐A) injection (50 U)
Number of subjects: 57
Study 36006207 — intervention group
Group type: COMPARATOR
Intervention: Saline injection (control)
Number of subjects: 57
Study 32666576 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-professional medication review (MPMR) service
Number of subjects: 826
Study 32666576 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 826
Study 35132024 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin enacarbil 600 mg twice daily starting the day before surgery continuing for 3 days thereafter
Number of subjects: 60
Study 35132024 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 35132024 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin enacarbil
Number of subjects: 60
Study 32389147 — intervention group
Group type: EXPERIMENTAL
Intervention: Dissociative seizures (DS) cohort
Number of subjects: 368
Study 32361698 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined aerobic and resistance exercise program during dialysis for 16 weeks
Number of subjects: 45
Study 32361698 — intervention group
Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 45
Study 34591227 — intervention group
Group type: EXPERIMENTAL
Intervention: IRLA with heated lidocaine gel (20 mL 2% lidocaine gel at 40 ℃)
Number of subjects: 153
Study 34591227 — intervention group
Group type: COMPARATOR
Intervention: IRLA with room temperature lidocaine gel (20 mL 2% lidocaine gel)
Number of subjects: 153
Study 34591227 — intervention group
Group type: COMPARATOR
Intervention: No local anesthesia
Number of subjects: 153
Study 35113456 — intervention group
Group type: EXPERIMENTAL
Intervention: 9-hour modified psychological first aid (PFA) training program
Number of subjects: 150
Study 35113456 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 150
Study 32265417 — intervention group
Group type: EXPERIMENTAL
Intervention: ANG-3777 (2 mg/kg, 3 once-daily IV infusions)
Number of subjects: 28
Study 32265417 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 32265417 — intervention group
Group type: EXPERIMENTAL
Intervention: ANG-3777
Number of subjects: 28
Study 32282539 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative endoscopy to assess recurrence within 12 months
Number of subjects: 0
Study 32282539 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic assessment in routine follow-up after first negative colonoscopy
Number of subjects: 0
Study 32282539 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative immunoprophylaxis in naïve patients with known risk factors
Number of subjects: 0
Study 32282539 — intervention group
Group type: EXPERIMENTAL
Intervention: Prescribing biologics over immunosuppressants based on risk factors
Number of subjects: 0
Study 32282539 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate prophylaxis for fistulizing phenotype, perianal disease, or concomitant colonic involvement
Number of subjects: 0
Study 32282539 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopy-driven treatment in long-standing disease after failure of thiopurines
Number of subjects: 0
Study 32282539 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopy-driven treatment in elderly patients
Number of subjects: 0
Study 32054425 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-rich fibrin (PRF) with decalcified freeze-dried bone allograft (DFDBA)
Number of subjects: 60
Study 32054425 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-rich fibrin (PRF) alone
Number of subjects: 60
Study 32054425 — intervention group
Group type: COMPARATOR
Intervention: Open flap debridement (OFD) alone
Number of subjects: 60
Study 35075174 — intervention group
Group type: EXPERIMENTAL
Intervention: Facial sheet masks applied for 5, 10, 15, 20, 25, and 30 minutes
Number of subjects: 175
Study 35075174 — intervention group
Group type: COMPARATOR
Intervention: Four types of facial sheet masks applied for 15 minutes
Number of subjects: 175
Study 34375749 — intervention group
Group type: EXPERIMENTAL
Intervention: Prompt to perform stress management exercise via apps
Number of subjects: 75
Study 34375749 — intervention group
Group type: COMPARATOR
Intervention: No prompt
Number of subjects: 75
Study 32644170 — intervention group
Group type: EXPERIMENTAL
Intervention: EvoTears (semi-fluorinated alkane eye drops), prescribed four times a day for 5 weeks
Number of subjects: 40
Study 35273223 — intervention group
Group type: EXPERIMENTAL
Intervention: Newly designed patch fabricated by blending poly(L-lactic acid) and poly(ε-caprolactone) exposed to amniotic fluid for 16 weeks
Number of subjects: 0
Study 35273223 — intervention group
Group type: COMPARATOR
Intervention: Newly designed patch fabricated by blending poly(L-lactic acid) and poly(ε-caprolactone) exposed to phosphate-buffered saline (PBS) for 16 weeks
Number of subjects: 0
Study 34535165 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine (HCQ) at a dose of 400 mg/daily for 8 weeks
Number of subjects: 0
Study 32564128 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatin plus gemcitabine (GP arm)
Number of subjects: 102
Study 32564128 — intervention group
Group type: COMPARATOR
Intervention: Carboplatin plus gemcitabine (GC arm)
Number of subjects: 102
Study 34233357 — intervention group
Group type: EXPERIMENTAL
Intervention: Ozonated water
Number of subjects: 16
Study 34233357 — intervention group
Group type: COMPARATOR
Intervention: Antimicrobial soap and water
Number of subjects: 16
Study 33079705 — intervention group
Group type: EXPERIMENTAL
Intervention: Urtica urens mother tincture (UUMT)
Number of subjects: 90
Study 33079705 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized homeopathy (IH)
Number of subjects: 90
Study 33079705 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized homeopathy (IH) + Urtica urens mother tincture (UUMT)
Number of subjects: 90
Study 33079705 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 90
Study 33394581 — intervention group
Group type: EXPERIMENTAL
Intervention: FEAR index in dysplastic hips (mean 5° ± 10°)
Number of subjects: 206
Study 33394581 — intervention group
Group type: EXPERIMENTAL
Intervention: FEAR index in borderline dysplastic hips
Number of subjects: 206
Study 33394581 — intervention group
Group type: EXPERIMENTAL
Intervention: FEAR index cutoff of -1.3°
Number of subjects: 206
Study 33394581 — intervention group
Group type: EXPERIMENTAL
Intervention: ROC-AUC for FEAR index
Number of subjects: 206
Study 33394581 — intervention group
Group type: EXPERIMENTAL
Intervention: FEAR index in older dysplastic hips
Number of subjects: 206
Study 33394581 — intervention group
Group type: COMPARATOR
Intervention: FEAR index in control hips
Number of subjects: 206
Study 32465450 — intervention group
Group type: EXPERIMENTAL
Intervention: HeartMate 3 (HM3) LVAD implantation
Number of subjects: 125
Study 35218601 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-centered consent process designed through collaboration with a patient advisory panel and a central institutional review board (CIRB)
Number of subjects: 0
Study 35218601 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote consent process
Number of subjects: 0
Study 35218601 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptive randomization
Number of subjects: 0
Study 35218601 — intervention group
Group type: EXPERIMENTAL
Intervention: Information sheet developed for patients and surrogates after enrollment
Number of subjects: 0
Study 32109255 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid Assistive Limb (HAL) training (4 days/week for 4 weeks)
Number of subjects: 32
Study 32109255 — intervention group
Group type: COMPARATOR
Intervention: Conventional gait training only
Number of subjects: 32
Study 34772904 — intervention group
Group type: EXPERIMENTAL
Intervention: Slackline training
Number of subjects: 28
Study 34772904 — intervention group
Group type: COMPARATOR
Intervention: Control condition (ergometer-based aerobic exercise)
Number of subjects: 28
Study 33823379 — intervention group
Group type: EXPERIMENTAL
Intervention: Scenario simulation-based education intervention and fever education booklet
Number of subjects: 160
Study 33823379 — intervention group
Group type: COMPARATOR
Intervention: Control group received only the fever education booklet
Number of subjects: 160
Study 36182773 — intervention group
Group type: EXPERIMENTAL
Intervention: MRUP at 10 min after methadone
Number of subjects: 100
Study 36182773 — intervention group
Group type: COMPARATOR
Intervention: Methadone alone without MRUP
Number of subjects: 100
Study 36214097 — intervention group
Group type: EXPERIMENTAL
Intervention: Worry (T1)
Number of subjects: 650
Study 36214097 — intervention group
Group type: EXPERIMENTAL
Intervention: Rumination (T1)
Number of subjects: 650
Study 34656192 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdiagnostic CBT
Number of subjects: 179
Study 34656192 — intervention group
Group type: COMPARATOR
Intervention: Single-diagnosis CBT
Number of subjects: 179
Study 34656192 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 179
Study 33208014 — intervention group
Group type: EXPERIMENTAL
Intervention: External diaphragmatic pacing (EDP)
Number of subjects: 50
Study 33208014 — intervention group
Group type: COMPARATOR
Intervention: Anti‐CCP therapy (negative control group)
Number of subjects: 50
Study 33307236 — intervention group
Group type: EXPERIMENTAL
Intervention: Er:YAG laser irradiation with PIPS technique
Number of subjects: 60
Study 33307236 — intervention group
Group type: EXPERIMENTAL
Intervention: Er:YAG laser irradiation with SWEEPS technique
Number of subjects: 60
Study 33307236 — intervention group
Group type: COMPARATOR
Intervention: Control group (no irradiation)
Number of subjects: 60
Study 36281151 — intervention group
Group type: EXPERIMENTAL
Intervention: TXA + DEXA (15 mg/kg TXA before skin incision and 3 hours later; 20 mg dexamethasone intravenously after the onset of anesthesia, and again 24 hours later)
Number of subjects: 100
Study 36281151 — intervention group
Group type: EXPERIMENTAL
Intervention: TXA + DEXA
Number of subjects: 100
Study 36281151 — intervention group
Group type: COMPARATOR
Intervention: TXA (placebo group)
Number of subjects: 100
Study 33402599 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemoradiotherapy (nCRT)
Number of subjects: 117
Study 35842755 — intervention group
Group type: EXPERIMENTAL
Intervention: Caloric Restriction (CR)
Number of subjects: 188
Study 35842755 — intervention group
Group type: COMPARATOR
Intervention: Control (ad lib diet)
Number of subjects: 188
Study 34237755 — intervention group
Group type: EXPERIMENTAL
Intervention: Midurethral sling
Number of subjects: 403
Study 34237755 — intervention group
Group type: COMPARATOR
Intervention: Midurethral sling alone
Number of subjects: 403
Study 34237755 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral and pelvic floor muscle therapy combined with midurethral sling
Number of subjects: 403
Study 32823599 — intervention group
Group type: EXPERIMENTAL
Intervention: Sedentary behaviour fragmentation (SBF)
Number of subjects: 35
Study 32823599 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous LIPA
Number of subjects: 35
Study 32823599 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 35
Study 35026462 — intervention group
Group type: EXPERIMENTAL
Intervention: Sigmoidectomy with primary anastomosis (PA)
Number of subjects: 119
Study 35026462 — intervention group
Group type: COMPARATOR
Intervention: Hartmann's Procedure (HP)
Number of subjects: 119
Study 33059580 — intervention group
Group type: COMPARATOR
Intervention: Diet-exercise
Number of subjects: 604
Study 33059580 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin
Number of subjects: 604
Study 33059580 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosuvastatin
Number of subjects: 604
Study 33059580 — intervention group
Group type: EXPERIMENTAL
Intervention: Pitavastatin
Number of subjects: 604
Study 32650074 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical benzoyl peroxide
Number of subjects: 4348
Study 32650074 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrogen peroxide
Number of subjects: 4348
Study 34786990 — intervention group
Group type: EXPERIMENTAL
Intervention: Foot-core training program (8 weeks, 3 times/week)
Number of subjects: 118
Study 34786990 — intervention group
Group type: EXPERIMENTAL
Intervention: Older age
Number of subjects: 118
Study 34786990 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher training volume
Number of subjects: 118
Study 33377533 — intervention group
Group type: EXPERIMENTAL
Intervention: Sealants applied to primary molars
Number of subjects: 90
Study 33377533 — intervention group
Group type: COMPARATOR
Intervention: Control (unsealed primary molars)
Number of subjects: 90
Study 33322063 — intervention group
Group type: EXPERIMENTAL
Intervention: DKB114
Number of subjects: 80
Study 33322063 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 36445625 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote Ischaemic Conditioning (RIC)
Number of subjects: 80
Study 36445625 — intervention group
Group type: COMPARATOR
Intervention: Sham
Number of subjects: 80
Study 34058011 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-head parallel design
Number of subjects: 155
Study 34058011 — intervention group
Group type: EXPERIMENTAL
Intervention: Split-head paired design
Number of subjects: 155